Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs.

about

Bone mineral density loss in postmenopausal onset rheumatoid arthritis is not greater than premenopausal onset disease.Effect of long-term low dose prednisolone administration on bone mineral density: Relating to non-compliant women with rheumatoid arthritis.

P2860

Q34586107-54601D7A-A9E7-4C63-B694-5D3CD090AD9C Q55092131-1B3D1BAF-7FD0-4EC4-A5FE-24EB67E9DEDC

P2860

Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs.

Item

http://www.wikidata.org/entity/Q36143682

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@ast

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@en

type

Item

label

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@ast

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@en

prefLabel

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@ast

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@en

P1476

Bone mineral density changes d ...... odifying-anti-rheumatic drugs.

@en

P2093

Behzad Heidari

http://www.w3.org/2001/XMLSchema#string

Mohammad Ali Ghazi Mirsaed

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.

Bone mineral density in nonsteroid treated early rheumatoid arthritis.

Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Effects of rheumatoid arthritis on bone.

Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density.

Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis.

Osteoporosis and inflammation.

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study

P304

354-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mahmoud Monadi

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26557285

http://www.w3.org/2001/XMLSchema#string

P932

4600131

http://www.w3.org/2001/XMLSchema#string

Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs.

about

P2860

P2860

Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932